| Schedule of Plan's Assets Fair Value Hierarchy |
| | | | | | | | | | | | | | | December 31, 2025 | | | Level 1 | | Level 2 | | Level 3 | | Total | Mutual Funds | | $ | 305,689,698 | | $ | - | | $ | - | | $ | 305,689,698 | Fresenius Medical Care AG Shares | | | 14,236,904 | | | - | | | - | | | 14,236,904 | Self-Directed Brokerage Accounts (a) | | | 107,058,423 | | | 763,788 | | | - | | | 107,822,211 | Interest-Bearing Cash | | | 17,906,546 | | | - | | | - | | | 17,906,546 | Total Investments at Fair Value | | $ | 444,891,571 | | $ | 763,788 | | $ | - | | | 445,655,359 | Total Investments at Net Asset Value* | | | | | | | | | | | | 3,193,820,709 | Total Investments | | | | | | | | | | | $ | 3,639,476,068 |
| | | | | | | | | | | | | | | December 31, 2024 | | | Level 1 | | Level 2 | | Level 3 | | Total | Mutual Fund | | $ | 30,397,222 | | $ | - | | $ | - | | $ | 30,397,222 | Fresenius Medical Care AG Shares | | | 15,861,109 | | | - | | | - | | | 15,861,109 | Self-Directed Brokerage Accounts (a) | | | 77,290,279 | | | 1,132,428 | | | - | | | 78,422,707 | Interest-Bearing Cash | | | 17,201,163 | | | - | | | - | | | 17,201,163 | Total Investments at Fair Value | | $ | 140,749,773 | | $ | 1,132,428 | | $ | - | | | 141,882,201 | Total Investments at Net Asset Value* | | | | | | | | | | | | 3,034,545,303 | Total Investments | | | | | | | | | | | $ | 3,176,427,504 |
* In accordance with subtopic 820-10, certain investments that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets available for benefits. (a) - Investments in brokerage accounts of Plan participants choosing the “Self-Directed Brokerage Accounts” investment option. Such investments consist of a variety of classes of common stocks, mutual funds, corporate bonds and other investments as directed by Plan participants.
|
| Schedule of Plan's investments with a reported NAV |
| | | | | | | | | | | | | | | | | | | | | | | Other | | Redemption | | | Fair Value | | Fair Value | | Redemption | | Redemption | | Notice | Investments | | December 31, 2025* | | December 31, 2024* | | Frequency | | Restrictions | | Period | BlackRock Equity Index Fund | | $ | 1,767,860,942 | | $ | 1,550,604,658 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock Russell 2000 Index Fund | | | 27,260,948 | | | 290,846,641 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock Mid Capitalization Equity Index Fund | | | 252,055,360 | | | 344,787,918 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock U.S. Debt Index Fund | | | 242,596,704 | | | 253,874,802 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock MSCI ACWI EX U.S. Index Fund | | | 492,346,514 | | | 441,356,082 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock U.S. Treasury Inflation Protection Securities Fund | | | 18,355,108 | | | 30,746,298 | | Daily | | None | | None | | | | | | | | | | | | | | BlackRock Emerging Markets Index Non-Lendable Fund | | | - | | | 122,328,904 | | Daily | | None | | None | | | | | | | | | | | | | | T. Rowe Price International Discovery Administrative | | | 94,738,348 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | Columbia Dividend Income Institutional | | | 119,055,694 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | Schroder International Alpha Fund | | | 67,582,951 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | Cohen & Steers U.S. Realty Fund Class A | | | 514,697 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | Pioneer Bond Fund | | | 56,789,004 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | GQG Partners Emerging Markets Equity CIT Fund | | | 54,664,439 | | | - | | Daily | | None | | None | | | | | | | | | | | | | | | | $ | 3,193,820,709 | | $ | 3,034,545,303 | | | | | | |
* The fair value of the investments has been estimated using the net asset value of the investment as a practical expedient.
|